DCP
GMED icon

Distillate Capital Partners’s Globus Medical GMED Stock Holding History

Distillate Capital Partners’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-167,647
Closed -$12.3M – 128
2025
Q1 		$12.3M Sell
167,647
-13,957
-8% -$1.15M 0.63% 96
2024
Q4 		$15M Buy
+181,604
New +$14.3M 0.74% 91
2024
Q3 		– Sell
-200,299
Closed -$13.7M – 84
2024
Q2 		$13.7M Buy
+200,299
New +$12M 0.73% 84

Other funds holding GMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
HRCM
Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Distillate Capital Partners's GMED Position: Q2 2025 in Review

Distillate Capital Partners sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 167,647 shares — an estimated $12.3M sold.

Distillate Capital Partners first reported a position in GMED in Q2 2024 and held it in 3 quarters. The position peaked at $15M in Q4 2024. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

  • Distillate Capital Partners reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
  • Distillate Capital Partners sold 167,647 Globus Medical shares in Q2 2025, an estimated $12.3M.
  • Distillate Capital Partners first reported a position in Globus Medical in Q2 2024 and held it in 3 quarters.
  • Distillate Capital Partners's Globus Medical position peaked at $15M in Q4 2024.
  • 480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on Distillate Capital Partners's 13F filing for Q2 2025, filed 13 Aug 2025.